España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Illumina
ILMN
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$140.14
3.15
2.30%
At close: -
$140.14
0
0.00%
After Hours: Nov 22, 4:48 PM EDT
Get Report
Comment
Illumina (ILMN) Forecast
News
Earnings
Illumina (ILMN) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Illumina (NASDAQ:ILMN) Stock
Illumina Stock (NASDAQ: ILMN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, November 20, 2024
Myriad Genetics Announces The Incorporation O...
Benzinga Newsdesk
Tuesday, November 19, 2024
Illumina Highlights TruSight Oncology Portfol...
Benzinga Newsdesk
Tuesday, November 12, 2024
Morgan Stanley Reinstates Equal-Weight on Ill...
Benzinga Newsdesk
Stephens & Co. Maintains Overweight on Illumi...
Benzinga Newsdesk
Monday, November 11, 2024
Piper Sandler Maintains Overweight on Illumin...
Benzinga Newsdesk
Wednesday, November 06, 2024
Baird Maintains Neutral on Illumina, Raises P...
Benzinga Newsdesk
Tuesday, November 05, 2024
TD Cowen Maintains Buy on Illumina, Raises Pr...
Benzinga Newsdesk
Wall Street Rallies On Election Day, Palantir Skyrockets, Bitcoin Tops $70,000: What's Driving Markets Tuesday?
Piero Cingari
UBS Maintains Neutral on Illumina, Raises Pri...
Benzinga Newsdesk
RBC Capital Maintains Outperform on Illumina,...
Benzinga Newsdesk
JP Morgan Maintains Neutral on Illumina, Rais...
Benzinga Newsdesk
Citigroup Maintains Buy on Illumina, Raises P...
Benzinga Newsdesk
Barclays Maintains Equal-Weight on Illumina, ...
Benzinga Newsdesk
Canaccord Genuity Maintains Hold on Illumina,...
Benzinga Newsdesk
Monday, November 04, 2024
Illumina Raises FY2024 Adj EPS Guidance from ...
Benzinga Newsdesk
Illumina Sees Q4 Sales $1.070B vs $1.08B Est
Benzinga Newsdesk
Illumina Q3 2024 Adj. EPS $1.14 Beats $0.88 E...
Benzinga Newsdesk
Wall Street Struggles Ahead Of Election Day, Energy Sector Outperforms, Solar Stocks Rise: What's Driving Markets Monday?
Piero Cingari
Looking Into Illumina's Recent Short Interest
Benzinga Insights
Thursday, October 31, 2024
Illumina Announces That It Will Present Updat...
Benzinga Newsdesk
Monday, October 28, 2024
If You Invested $100 In This Stock 20 Years Ago, You Would Have $4,600 Today
Benzinga Insights
Thursday, October 17, 2024
Leerink Partners Maintains Outperform on Illu...
Benzinga Newsdesk
This Illumina Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Avi Kapoor
HSBC Upgrades Illumina to Buy, Announces $180...
Benzinga Newsdesk
Wednesday, October 16, 2024
$100 Invested In This Stock 20 Years Ago Would Be Worth $4,600 Today
Benzinga Insights
Tuesday, October 15, 2024
Smart Money Is Betting Big In ILMN Options
Benzinga Insights
Thursday, October 10, 2024
Decoding 14 Analyst Evaluations For Illumina
Benzinga Insights
RBC Capital Reiterates Outperform on Illumina...
Benzinga Newsdesk
Wednesday, October 09, 2024
Watching 10x Genomics; Shares Move Higher As ...
Benzinga Newsdesk
Illumina Unveils MiSeq i100 Series Sequencing...
Benzinga Newsdesk
How Is The Market Feeling About Illumina?
Benzinga Insights
Tuesday, October 01, 2024
Here's How Much You Would Have Made Owning Illumina Stock In The Last 20 Years
Benzinga Insights
Friday, September 20, 2024
VNDA Stock Down as FDA Rejects NDA for Tradipitant in Gastroparesis
Zacks
Wednesday, September 18, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Friday, September 13, 2024
FULC Stock Falls as Muscle Disorder Study Misses Primary Goal
Zacks
Wednesday, September 11, 2024
$1000 Invested In This Stock 20 Years Ago Would Be Worth $38,000 Today
Benzinga Insights
Monday, September 09, 2024
IMVT Stock Up on Upbeat Data From Graves' Disease Study of Batoclimab
Zacks
Tuesday, September 03, 2024
Corcept Shares Rise More Than 45% in Six Months: Here's Why
Zacks
ALNY Down Despite Positive Data From Heart Disease Drug Study
Zacks
European Court Rules In Favor Of Illumina In Fight Against Probe Into Grail Deal, Asks Not To Pay $478M Fine
Vandana Singh
Illumina Hails ECJ Ruling, Eliminates €432M F...
Benzinga Newsdesk
Monday, September 02, 2024
Peering Into Illumina's Recent Short Interest
Benzinga Insights
Wednesday, August 28, 2024
Here's How Much $1000 Invested In Illumina 20 Years Ago Would Be Worth Today
Benzinga Insights
ILMN's TSO Comprehensive IVD Test Secures FDA Approval as CDx
Zacks
Argus Research Upgrades Illumina to Buy, Anno...
Benzinga Newsdesk
Tuesday, August 27, 2024
FDA Approves Illumina Cancer Biomarker Test W...
Benzinga Newsdesk
Tuesday, August 20, 2024
Mirum Banks on Livmarli, Overdependence a Concern
Zacks
Monday, August 19, 2024
S&P 500, Nasdaq 100 Extend 8-Session Winning Streak As Wall Street Jitters 'Go Poof': Monday's Key Stock Movers
Piero Cingari
AN2 Therapeutics Plunges 66% in a Month: Here's Why
Zacks
This HP Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
Avi Kapoor
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch